更年期女性的激素替代-猫眼课题宝

更年期女性的激素替代

批准号：

3745466

负责人：

S M HARMAN

金额：

$0.0万

依托单位：

NATIONAL INSTITUTE ON AGING

依托单位国家：

美国

项目类别：

财政年份：

资助国家：

美国

项目状态：

未结题

起止时间：

至

来源：

https://reporter.nih.gov/project-details/3745466

关键词：

aging body composition bone density combination chemotherapy drug adverse effect endocrine pharmacology estrogens female hormone therapy human old age (65+) human subject human therapy evaluation oral administration postmenopause progestins

项目摘要

项目成果

S M HARMAN的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

We are studying 30 women 65-75 years of age treated for 2 y with constant oral estrogen/low dose daily progestin (ERT) and 30 age-matched BLSA controls for bone loss (DEXA) and biochemical indices of bone turnover, plasma lipids, anthropometric indices, DEXA measures of body fat, and vaginal maturation indices. Mood, symptoms of estrogen deficiency, and side effects of hormone replacement therapy are assessed. Minor breast tenderness and vaginal bleeding are the only adverse effects observed. Treated women showed a 3.8% decrease in total cholesterol (NS) with a 16% increase in HDL and a 17% decrease in LDL (both p<0.001), and no significant change in plasma triglycerides. DEXA scans revealed a decrease in percent body fat (p<0.03) and increases in lean body mass (p<0.03) and bone mineral density (lumbar spine +7%; femoral trochanter +9%, both p<0.01). Data suggest that ERT in older postmenopausal women improves metabolic function and results in favorable changes in body composition. We find a favorable risk/benefit ratio for ERT in older postmenopausal women.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文